January 12 2018 - Ex-Insys sales manager seeks ban on mentioning ‘opioid crisis’ at trial

Ex-Insys sales manager seeks ban on mentioning ‘opioid crisis’ at trial, tax law changes and healthcare firms, AstraZeneca gets FDA ok for PARP inhibitor, and more

For banking news and anonymous forums, be sure to check out cafebanking.com